Finepoint Capital LP Argenx Se Transaction History
Finepoint Capital LP
- $963 Million
- Q3 2024
A detailed history of Finepoint Capital LP transactions in Argenx Se stock. As of the latest transaction made, Finepoint Capital LP holds 54,428 shares of ARGX stock, worth $34 Million. This represents 3.06% of its overall portfolio holdings.
Number of Shares
54,428
Previous 54,028
0.74%
Holding current value
$34 Million
Previous $23.2 Million
27.05%
% of portfolio
3.06%
Previous 6.69%
Shares
5 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.63 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.19 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.55 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.06 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$773 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...